Analytical Data
-
Gene name
IGSF11
- Application
-
Alternative Names
IGSF11；BTIGSF；CXADRL1；VSIG3；Immunoglobulin superfamily member 11
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q5DX21
-
Expression Region
22-245aa
-
AA Sequence
SLEVSESPG SIQVARGQPA VLPCTFTTSA ALINLNVIWM VTPLSNANQP EQVILYQGGQ MFDGAPRFHG RVGFTGTMPA TNVSIFINNT QLSDTGTYQC LVNNLPDIGG RNIGVTGLTV LVPPSAPHCQ IQGSQDIGSD VILLCSSEEG IPRPTYLWEK LDNTLKLPPT ATQDQVQGTV TIRNISALSS GLYQCVASNA IGTSTCLLDL QVISPQPRNI GLIAG
-
Molecular Weight
52 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
IGSF11 (Immunoglobulin Superfamily Member 11) is a member of the immunoglobulin superfamily that plays a notable role in cell adhesion and communication. Its expression is observed in various tissues, particularly in the nervous system and immune cells, suggesting its potential involvement in neurodevelopmental processes and immune responses. Recent studies have indicated that IGSF11 may influence tumor progression and has been implicated in the regulation of T-cell function, making it a promising target for cancer immunotherapy. The recombinant protein of IGSF11 is produced for further investigation into its biological functions, structural properties, and potential as a therapeutic agent. Understanding the molecular mechanisms and pathways in which IGSF11 is involved could provide insights into its role in disease mechanisms and therapeutic strategies. As research progresses, the creation of IGSF11 recombinant protein enables researchers to explore its therapeutic applications, particularly in modulating immune responses and its potential effects in various cancers, thus paving the way for future clinical applications.
